Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xeris Pharmaceuticals Inc (NQ: XERS ) 3.220 -0.010 (-0.31%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Xeris Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 Next > The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings August 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue July 29, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Xeris Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021 July 29, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Xeris Pharmaceuticals Announces Executive Changes as Part of Its Strategy to Position the Company for Long-Term Commercial Success July 28, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Xeris Pharma, Tetris Ink Commercialization Pact For Ogluo In Europe July 19, 2021 Xeris Pharmaceuticals Inc (NASDAQ: XERS) has entered into an exclusive agreement with Tetris Pharma Limited to commercialize Ogluo in the European... Via Benzinga Xeris Pharmaceuticals Enters Into an Exclusive License and Supply Agreement with Tetris Pharma Limited to Commercialize Ogluo® in Europe July 19, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) July 02, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Get Ready for a XERS Stock Squeeze! Why One Analyst Thinks Xeris Could Be the Next AMC June 03, 2021 XERS stock could very well be the next stock to get the short squeeze treatment, even without a r/WallStreetBets co-sign. Via InvestorPlace 55 Biggest Movers From Yesterday June 04, 2021 Gainers DLocal Limited (NASDAQ: DLO) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO. GTT... Via Benzinga Topics Initial Public Offering Exposures Securities Market 12 Health Care Stocks Moving In Thursday's Intraday Session June 03, 2021 Gainers Kindred Biosciences (NASDAQ:KIN) shares increased by 24.08% to $6.75 during Thursday's regular session. Kindred Biosciences's stock is trading at a volume... Via Benzinga INVESTIGATION ALERT: Halper Sadeh LLP Investigates KSU, INSW, LMNX, XERS; Shareholders are Encouraged to Contact the Firm May 27, 2021 NEW YORK, NY / ACCESSWIRE / May 27, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Kansas City Southern (NYSE:KSU) concerning... From Halper Sadeh LLP Via AccessWire Topics Fraud Exposures Legal Xeris Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Xeris Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – XERS May 24, 2021 From Halper Sadeh LLP Via Business Wire Mid-Afternoon Market Update: Dow Jumps 250 Points; Scopus BioPharma Shares Spike Higher May 24, 2021 Toward the end of trading Monday, the Dow traded up 0.75% to 34,462.98 while the NASDAQ rose 1.64% to 13,691.64. The S&P also rose, gaining 1.25% to 4,207.76. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities Mid-Day Market Update: Crude Oil Rises 2.5%; NGM Biopharmaceuticals Shares Plunge May 24, 2021 Midway through trading Monday, the Dow traded up 0.58% to 34,405.22 while the NASDAQ rose 1.43% to 13,663.92. The S&P also rose, gaining 1.04% to 4,199.05. The U.S. has the... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Mid-Morning Market Update: Markets Open Higher; Xeris Pharmaceuticals To Acquire Strongbridge Biopharma May 24, 2021 Following the market opening Monday, the Dow traded up 0.50% to 34,378.59 while the NASDAQ rose 1.18% to 13,629.81. The S&P also rose, gaining 0.83% to 4,190.35. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities Strongbridge Shares Shoot Higher After Xeris' Buyout Deal At $267M May 24, 2021 Xeris Pharmaceuticals Inc (NASDAQ: XERS) has agreed to acquire Strongbridge Biopharma plc (NASDAQ: SBBP) for stock and contingent value rights (CVRs),... Via Benzinga Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases May 24, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma Plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases May 24, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Xeris Pharmaceuticals: Q1 Earnings Insights May 13, 2021 Shares of Xeris Pharmaceuticals (NASDAQ:XERS) rose 1.8% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 66.29%... Via Benzinga Xeris Pharmaceuticals Reports First Quarter 2021 Financial Results and Recent Highlights May 13, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Xeris Pharmaceuticals to Webcast Upcoming Presentations May 10, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Earnings Scheduled For May 13, 2021 May 13, 2021 Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... Via Benzinga Xeris Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021 May 06, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire Xeris Pharmaceuticals Announces Extension of the Interest-Only Period of Its Debt Facility With Oxford Finance and Silicon Valley Bank May 06, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire NASDAQ:XERS Shareholder Notice: Investigation over Potential Wrongdoing at Xeris Pharmaceuticals, Inc. May 05, 2021 San Diego, CA -- (SBWIRE) -- 05/05/2021 -- Certain directors of Xeris Pharmaceuticals, Inc. are under investigation over potential breaches of fiduciary duties. Via SBWire Xeris Pharmaceuticals Receives U.K. MHRA Approval of Ogluo® (glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus April 29, 2021 From Xeris Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs April 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:... Via Benzinga With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors? April 12, 2021 A new, easier-to-administer treatment for severe hypoglycemia has observers and investors wondering where its creators will go next. Via The Motley Fool < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
